Skip to main content
. Author manuscript; available in PMC: 2015 May 6.
Published in final edited form as: Nature. 2014 Sep 3;515(7525):138–142. doi: 10.1038/nature13601

Extended Data Figure 4. Neutralization of 35O22 against pseudovirus mutants known to knock out activity against known glycan-specific antibodies.

Extended Data Figure 4

a, Neutralization of 35O22 against JRCSF or KER2018.11 with or without the N160K mutation. PG9 and PG16 were used as positive controls. b, Neutralization of 35O22 against N332A mutants of JRCSF. PGT121 was used as a positive control. c, Neutralization of 35O22 against N234S, T236K and N276D mutants of 3337.V2.C6. 8ANC195 was used as a positive control. Error bars denote one standard error of the mean (s.e.m.).